A method for increasing SAMe production

By overexpressing the apt1-prs128 gene in the basic strain, the yield of SAMe was improved, the problem of low yield of microbial fermentation method was solved, and efficient and economical SAMe production was achieved.

CN118109540BActive Publication Date: 2024-12-03SUZHOU BIOSYNTHETICA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410321771.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-20
Publication Date
2024-12-03
Estimated Expiration
2044-03-20

AI Technical Summary

Technical Problem

The current microbial fermentation method produces S-adenosine-L-methionine (SAMe) with low yields and is difficult to meet the demand.

Method used

The apt1-prs128 gene was overexpressed in the basal strains expressing SAMe, and genetically engineered strains with increased SAMe yield were screened through shake flask fermentation, and SAMe production was performed using this method.

Benefits of technology

The output of SAMe has been increased from 1.4-1.6g/L to 1.7-2.3g/L. It is simple to operate, low cost, fast production rate, and easy to expand scale.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118109540B_ABST
    Figure CN118109540B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of genetic engineering, and specifically relates to a method for increasing the production of SAMe, an engineered bacterium and an application thereof. The method for increasing the production of SAMe provided by the present invention comprises overexpressing the apt1-prs128 gene in a basic strain expressing SAM2, and screening out a genetically engineered strain with increased SAMe production after shake flask fermentation. The method is simple to operate, low in cost, fast in production rate, and easy to scale up.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of genetic engineering and microbial fermentation, and specifically relates to a method for increasing SAMe production. Background Art

[0002] S-adenosyl-L-methionine (SAMe) is an important metabolic intermediate that exists in all organisms and plays a key role in various biological reactions. SAMe can act as a cofactor to provide a methyl donor for methyltransferases. [1] SAMe is also used as a source of methylene, amino, ribosyl moieties, and aminopropyl groups. [2] SAMe is the second most commonly used enzyme substrate, after ATP [3] SAMe exists in all eukaryotic cells and is a physiologically active molecule that is ubiquitous in human tissues and body fluids. It is mainly suitable for intrahepatic cholestasis before and due to cirrhosis, and intrahepatic cholestasis during pregnancy. It can convert abnormal liver function caused by various reasons to normal.

[0003] The main methods for producing SAMe include chemical synthesis, enzymatic synthesis and microbial fermentation. There are three main ways to prepare SAMe by chemical synthesis: (1) using 5′-methylthioadenosine and DL-2-amino-4-bromobutyric acid to chemically synthesize racemic SAMe, and 50% of the synthesized SAMe has biological activity; (2) through S-adenosylhomocysteine ​​(SAH) and methyl donor CH3I or (CH3)3S catalytic synthesis, the reaction substrate SAH is expensive, and the product contains 20%-30% of biologically inactive (R, S)-SA Me isomer; (3) using cheap adenosine as substrate and thionyl chloride to react to prepare 5-(chloromethyl)adenosine hydrochloride; using L-methionine as substrate to generate L-homocysteine ​​at -30 to -40°C; using 5-(chloromethyl)adenosine hydrochloride and L-homocysteine ​​as substrates to react at 70-80°C to obtain S-adenosylhomocysteine ​​(SAH); using trimethyloxonium tetrafluoroborate as a methyl donor to methylate SAH to obtain the final product SAMe. This method for synthesizing SAMe has the disadvantages of low yield, harsh reaction conditions, multiple isomers of reaction products, difficulty in separation and purification, and environmental pollution, and is now rarely used.

[0004] The enzymatic synthesis method uses SAMe synthase to catalyze the substrate L-methionine and ATP to produce SAMe. SAMe synthase has triphosphatase activity, which decomposes triphosphate into pyrophosphate and phosphoric acid. This method has a clear process and the extracted SAMe is of high purity, but the production process is complicated, time-consuming and costly.

[0005] Microbial fermentation can utilize cheap production raw materials and synthesize SAMe through specific microbial metabolism. It is simple to operate, low in cost, and has a fast production rate and is easy to scale up. Therefore, the production of SAMe by fermentation has received more and more attention. Some microorganisms, especially strains of Saccharomyces, can accumulate higher concentrations of SAMe in cells when grown in a culture medium containing L-methionine. Bioactive SAMe can be obtained by large-scale fermentation and extraction and purification of these microorganisms. As the demand for SAMe continues to increase, more and more studies have been conducted on the use of genetic engineering methods to transform and produce SAMe. However, the existing microbial fermentation method has the problem of relatively low yield. Therefore, the present invention provides a method for improving SAMe yield to solve this problem.

[0006] [1]Rudenko AY, Mariasina SS, Sergiev PV, Polshakov VI. (2022). Analogs of S-Adenosyl-L-Methionine in Studies of Methyltransferases. Mol Biol, 56(2):229-250.

[0007] [2] Fontecave M., Atta M., Mulliez E. (2014). S-Adenosylmethionine: nothing goes to waste. Trends Biochem. Sci, 29: 243-249.

[0008] [3]Cantoni GL.(1975).Biological methylation:selected aspects.AnnuRev.Biochem.,44:435-451. Summary of the invention

[0009] The method for increasing SAMe production provided by the present invention comprises overexpressing the apt1-prs128 gene in a basic strain expressing SAMe, and screening out a genetically engineered strain with increased SAMe production after shake flask fermentation. The method is simple to operate, low in cost, fast in production rate, and easy to scale up.

[0010] the term

[0011] In the present invention, SAMe: ​​S-adenosyl-L-methionine, is an important metabolic intermediate, exists in all organisms, and plays a key role in various biological reactions.

[0012] In the present invention, the recombinant strain refers to a strain obtained through genetic engineering, which can be used to specifically express a certain function.

[0013] In the present invention, shake flask fermentation is a fermentation method, usually used for small-scale production or testing, in which bottles containing microorganisms and nutrients are shaken under controlled conditions to promote growth and metabolism.

[0014] In one aspect, the invention provides a method for increasing SAMe production.

[0015] The method comprises overexpressing the apt1-prs128 gene in a basic strain expressing SAMe.

[0016] Specifically, the nucleotide sequence of the apt1-prs128 gene includes SEQ ID No. 15 or a functional fragment thereof.

[0017] Specifically, the basic strain is Saccharomyces.

[0018] Preferably, the basic strain is Saccharomyces cerevisiae.

[0019] On the other hand, the present invention also provides a genetically engineered strain for expressing SAMe.

[0020] The apt1-prs128 gene is overexpressed in the genetically engineered strain; the nucleotide sequence of the apt1-prs128 gene includes SEQ ID No.15 or a functional fragment thereof.

[0021] Specifically, the genetically engineered strain includes the expression of apt1-prs128 gene.

[0022] Specifically, the genetically engineered strain is yeast SHF16G or yeast SHF16.

[0023] Specifically, the deposit number of the yeast SHF16 is CGMCC No.28947.

[0024] On the other hand, the present invention also provides an application of overexpressing apt1-prs128 gene in increasing SAMe production.

[0025] Specifically, the application includes overexpressing the apt1-prs128 gene in a basic strain expressing SAMe; the nucleotide sequence of the apt1-prs128 gene includes SEQ ID No.15 or a functional fragment thereof.

[0026] In yet another aspect, the present invention also provides the use of the aforementioned genetically engineered strain in the production of SAMe.

[0027] Specifically, the genetically engineered strain is used to increase the production of SAMe.

[0028] In another aspect, the present invention also provides a method for producing SAMe.

[0029] Specifically, the production method comprises the following steps:

[0030] (1) activating the aforementioned genetically engineered strain;

[0031] (2) Fermentation;

[0032] (3) Extraction of SAMe.

[0033] Specifically, the step (1) comprises: taking a single bacterial colony and inoculating it into YPD and activating it overnight;

[0034] The step (2) comprises: transferring the activated seeds to a fermentation medium for fermentation;

[0035] The step (3) comprises: taking fermentation broth, adding perchloric acid, water bathing, centrifuging, filtering the supernatant with an aqueous membrane, and then detecting with HPLC.

[0036] SEQ ID No.1:

[0037]

[0038] SEQ ID No.2:

[0039] ;

[0040] SEQ ID No.3:

[0041]

[0042] SEQ ID No.4:

[0043] TTTGTTTGTTTATGTGTGTTTATTCGAAACTAAG;

[0044] SEQ ID No.5:ACCCGGGgcgaatttcttatg;

[0045] SEQ ID No.6:CTTAGTTTCGAATAAACACACATAAACAAACAAAATGTCTATAGCAAGTTATGCCCAAG;

[0046] SEQ ID No.7:cataagaaattcgcCCCGGGTTCATTTTTTCAACGCTTCCTTTTGAGC;

[0047] SEQ ID No.8:

[0048]

[0049] SEQ ID No.9:

[0050] AtgcctgatatgaagctttttgctggtaacgccaccccggaactagcacaacgtattgccaaccgcctgtacacttcactcggcgacgccgctgtaggtcgctttagcgatggcgaagtcagcgtacaaattaatgaaaatgtacgcggtggtgatattttcatcatccagtccacttgtgcccctactaacgacaacctgatggaattagtcgttatggttgatgccctgcgtcgtgcttccgcaggtcgtatcaccgctgttatcccctactttggctatgcgcgccaggaccgtcgcgtccgttccgctcgtgtaccaatcactgcgaaagtggttgcagacttcctctccagcgtcggtgttgaccgtgtgctgacagtggCtctgcacgctgaacagattcagggtttcttcgacgttccggttgataacgtatttggtagcccgatcctgctggaagacatgctgcagctgaatctggataacccaattgtggtttctccggacatcggcggcgttgtgcgtgcccgcgctatcgctaagctgctgaacgataccgatatggcaatcatcgacaaacgtcgtccgcgtgcgaacgtttcacaggtgatgcatatcatcggtgacgttgcaggtcgtgactgcgtactggtcgatgatatgatcgacactggcggtacgctgtgtaaagctgctgaagctctgaaagaacgtggtgctaaacgtgtatttgcgtacgcgactcacccgatcttctctggcaacgcggcgaacaacctgcgtaactctgtaattgatgaagtcgttgtctgcgataccattccgctgagcgatgaaatcaaatcactgccgaacgtgcgtactctgaccctgtcaggtatgctggccgaagcgattcgtcgtatcagcaacgaagaatcgatctctgccatgttcgaacactaa;

[0051] SEQ ID No.10:

[0052]

[0053] SEQ ID No.11:TTTGTAATTAAAACTTAGATTAGATTGCTATGC;

[0054] SEQ ID No.12:GAATTCTGCAGATATCCATCACACTG;

[0055] SEQ ID No.13:CTAATCTAAGTTTTAATTACAAAAtgcctgatatgaagctttttgctgg;

[0056] SEQ ID No.14:CAGTGTGATGGATATCTGCAGAATTCttagtgttcgaacatggcagagatcg;

[0057] SEQ ID No.15:

[0058]

[0059] SEQ ID No.16:

[0060]

[0061] SEQ ID No.17:

[0062]

[0063] SEQ ID No.18: GTATAATGTTACATGCGTACACGCGTCTG;

[0064] SEQ ID No.19: gcaacctgacctacaggaaagagttac;

[0065] SEQ ID No.20: CAGACGCGTGTACGCATGTAACATTATAC;

[0066] SEQ ID No.21: gtaactctttcctgtaggtcaggttgc;

[0067] SEQ ID No. 22: CTGAGAAATATGTGAATGTTGAGataattg;

[0068] SEQ ID No. 23: CTGTTGGAATAGAAATCAACTATCatctac.

[0069] Beneficial effects of the present invention:

[0070] The present invention improves the SAMe yield by overexpressing the corresponding gene in the basic strain expressing SAM2, the SAMe yield of the basic strain fermentation is 1.4-1.6 g / L, and the SAMe yield of the strain overexpressing the apt1-prs128 gene fermentation is 1.7-2.3 g / L. The method is simple to operate, low in cost, fast in production rate, and easy to scale up.

[0071] Deposit certificate

[0072] Deposited strain: SHF16;

[0073] Classification and nomenclature: Saccharomyces cerevisiae;

[0074] Deposit number: CGMCC No.28947;

[0075] Deposit date: November 13, 2023;

[0076] Depository: General Microbiology Center, China Culture Collection Administration. BRIEF DESCRIPTION OF THE DRAWINGS

[0077] Figure 1 This is a comparison chart of HPLC peaks.

[0078] Figure 2 This is the result of plasmid overexpression.

[0079] Figure 3 This is the initial screening result of SHF16G fermentation.

[0080] Figure 4 This is the result of SHF16G fermentation rescreening.

[0081] Figure 5 This is the result of screening of SHF16 resistant clones. DETAILED DESCRIPTION

[0082] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.

[0083] In the following embodiments:

[0084] YPD liquid medium: 20 g / L glucose, 10 g / L yeast powder, 20 g / L soy peptone FP410, pH 6.5.

[0085] YPD plate: YPD liquid medium with 0.2% agar added.

[0086] YPG (2% galactose): 2 mL of YPD without glucose, plus 160 μL of galactose.

[0087] O culture medium: 50 g / L glucose, 5 g / L yeast powder, 10 g / L peptone, 0.5 g / L magnesium sulfate heptahydrate, 2 g / L dipotassium hydrogen phosphate, 4 g / L potassium dihydrogen phosphate, and 1.5 g / L L-methionine.

[0088] G418: is an aminoglycoside antibiotic purchased from Yisheng Biotechnology, catalog number 60220ES08.

[0089] BY4742 yeast: purchased from Miaoling Biotechnology, product number T0081.

[0090] Phleo plate: Phleomycin, purchased from Yisheng Biotechnology, catalog number 60217ES20.

[0091] Basic Example 1 Method for Genetic Manipulation of Saccharomyces cerevisiae

[0092] (1) Preparation of yeast competent for electroporation: Yeast competent for electroporation was prepared using the sorbitol method.

[0093] (2) Plasmid transformation: 0.5 μg of plasmid was added to competent cells, mixed and added to a 2 mm electroporation cup, left for 5-10 min, and the integrated fragment was transformed by electroporation. 0.5 mL of YPD liquid medium was immediately added and resuscitated at 30°C for 2 h. 120 μL of the medium was spread on a YPD plate supplemented with 0.5 g / L G418, cultured at 30°C, and transformants were selected.

[0094] (3) Transformation of δ integration fragment: About 10 μL of 2-3 μg integration fragment was added to competent cells, mixed and added to a 2 mm electroporation cup, left for 5-10 min, and transformed by electroporation. 0.5 mL of YPD liquid culture medium was immediately added and resuscitated at 30°C for 2 h. 120 μL of the culture medium was taken out and spread on a YPD plate with different concentrations of G418 added. The screening concentrations of G418 were 1 g / L, 2 g / L, and 3 g / L.

[0095] Basic Example 2 Method for producing SAMe by shake flask fermentation of Saccharomyces cerevisiae

[0096] (1) Production of SAMe by shake flask fermentation of Saccharomyces cerevisiae

[0097] A single colony was picked from a YPD plate containing 0.5 g / L G418 and inoculated into a test tube containing 4 mL YPD liquid medium, and activated overnight at 30°C and 250 rpm. At 2 pm the next day, 400 μL of the seeds cultured for about 20 hours were transferred to 20 mL O medium with L-Met as the fermentation substrate, cultured at 30°C and 250 rpm, and fermented for 24 hours, and 0.5 mL of 0.75 g / L L-Met (mother liquor concentration was 30 g / L) was added to continue fermentation for 24 hours.

[0098] (2) Extraction of SAMe

[0099] Take 500 μL of fermentation broth, add 1 mL of 1.5 mol / L perchloric acid, bathe in a 40°C water bath for half an hour, centrifuge at 8000 r / min for 10 min, filter the supernatant with a 0.22 μm aqueous membrane, and detect by HPLC.

[0100] (3) HPLC detection

[0101] The chromatographic column was Welch Ultimate Aq-C18 (4.6*250mm, 5μm), the detection was performed by UV detector, the wavelength was 254nm, the initial flow rate was 1.0mL / min, the flow rate increased to 1.2mL / min at 7min, the column temperature was 30℃, the injection volume was 5μL, the mobile phase A was 10mM sodium octane sulfonate and 50mM potassium dihydrogen phosphate, the pH was adjusted to 3.0 with phosphoric acid, the mobile phase B was acetonitrile, the elution was isocratic, the elution ratio was A:B=82:18, and the elution time was 11min. The HPLC spectrum of SAMe peak is shown in Figure 1.

[0102] Example 1 SHF16G integration fragment

[0103] 1. Plasmid overexpression of APT1-PRS128

[0104] 1.1 Construction of pHF130 (pHA180-pGPD-APT1) plasmid

[0105] 1.1.1 Using pHA180 (basic plasmid constructed in this laboratory) as template, whose nucleotide sequence is shown in SEQ ID No. 1, PCR was performed with primer pair GPD-homL and GPD-homR (Table 1) to obtain a 5988 bp pHF130 fragment.

[0106] 1.1.2 Using the BY4742 yeast genome as a template, PCR was performed with primer pair APT1-homL and APT1-homR (Table 1) to obtain a 619 bp APT1 fragment with homology arms, the nucleotide sequence of which is shown in SEQ ID No.2.

[0107] 1.1.3 The pHF130 fragment obtained above and the APT1 fragment with homology arms were recombined into a vector containing Escherichia coli ori and Amp, and Saccharomyces cerevisiae TEF promotor, GPD promotor and KanMX components through seamless cloning (GBclonart seamless cloning kit, Suzhou Shenzhou Gene Co., Ltd.) to obtain plasmid pHF130. The nucleotide sequence of pHF130 is shown in SEQ ID No.3.

[0108] Table 1

[0109]

[0110] 1.2 Construction of pHF140 (pHA180-pTEF1-prs128-pGPD-APT1) plasmid

[0111] 1.2.1 Using pHF130 as template and primer pair TEF-homL and TEF-homR (Table 2) PCR was performed to obtain a 6505 bp pHF140 fragment, the nucleotide sequence of which is shown in SEQ ID No.8.

[0112] 1.2.2 Ribose phosphate pyrophosphokinase (Prs) catalyzes the reaction of 5-phosphoribose with ATP to synthesize PRPP. However, Prs is subject to feedback inhibition by ADP. By mutating the aspartic acid at position 128 of Prs to alanine to obtain Prs128, the feedback inhibition of ADP can be relieved.

[0113] Using pHX297 (pEZ07-prs128) plasmid as template and primer pair prs128-homL and prs128-homR (Table 2) PCR was performed to obtain a 997 bp prs128 fragment with homology arms, the nucleotide sequence of which is shown in SEQ ID No.9.

[0114] 1.2.3 The pHF140 fragment obtained above and the prs128 fragment with homology arms were recombined into a vector containing Escherichia coli ori and Amp, and Saccharomyces cerevisiae TEF promoter, GPD promoter and KanMX components through seamless cloning (GBclonart seamless cloning kit, Suzhou Shenzhou Gene Co., Ltd.) to obtain plasmid pHF140. The nucleotide sequence of pHF140 is shown in SEQ ID No.10.

[0115] 1.2.4 The pHF140 plasmid was transformed into SHF14 (a diploid yeast genetic engineering strain for producing SAMe constructed in this experiment, derived from SHF01) according to the method of Basic Example 1, and the obtained transformant was fermented according to the above-mentioned shake flask fermentation method. The results are shown in Figure 2 , the SAMe yield of SHF14 fermentation was

[0116] The SAMe production of SHF14 / pHF140 fermentation was 1.4 g / L and 1.6 g / L, and the SAMe production was increased by overexpression of apt1-prs128.

[0117] Table 2

[0118]

[0119] 2. Delta Integration of the prs128-APT1 Gene

[0120] 2.1 Construction of prs128-APT1 integration plasmid

[0121] 2.1.1 Using pHF140 as template and primer pair YHF279-homL and YHF280-homR, PCR was performed to obtain a 3026 bp prs128-APT1 fragment. The nucleotide sequence of the gene is SEQ ID NO.15.

[0122] 2.1.2 Using pHF85 as template and primer pair YHF281-homL and YHF282-homR, PCR was performed to obtain a 4923 bp pHF143 fragment with homology arms.

[0123] 2.1.3 The prs128-APT1 fragment with homology arms and pHF143 fragment obtained above were recombined into a vector containing Escherichia coli ori, Amp and Amp (Bacillus) components through seamless cloning (GBclonart seamless cloning kit, Suzhou Shenzhou Gene Co., Ltd.) to obtain the prs128-APT1 integration plasmid pHF143. The nucleotide sequence of pHF143 is shown in SEQ ID No.16.

[0124] 2.1.4 Using pHF143 plasmid as template and primer pair 3delta-R and 5delta-F (Table 3), PCR was performed to obtain a 5187 bp SHF16G integration fragment with a nucleotide sequence of SEQ ID No.17.

[0125] 2.2 Multi-copy integration of prs128-APT1 gene

[0126] 2.2.1 The integration fragment in 2.1.4 was transformed into SHF14 (a genetically engineered diploid yeast strain for producing SAMe constructed in this experiment) according to the above-mentioned Saccharomyces cerevisiae gene manipulation method to obtain transformants.

[0127] 2.2.2 The high-yield strain screened out by the shake flask fermentation method in Basic Example 2 was named SHF16G. Figure 3 , 4 As shown, the SAMe production of SHF14 fermentation was 1.4-1.6 g / L, and the SAMe production of SHF16G fermentation was 1.7-2.3 g / L. It can be seen that the high-yield strain screened after the integration of prs128-APT1 gene δ has increased SAMe production.

[0128] Table 3

[0129]

[0130] Example 2 SHF16G Antimicrobial

[0131] According to the yeast genetic engineering method, pSH65 plasmid (purchased from Yisheng Biotechnology, catalog number P1352) was transformed into SHF16G for sterilization. The transformant was inoculated with YPG (2% galactose) and induced for 2-3 hours. The 10 -2 times (990 μL of sterile water plus 10 μL of bacterial solution), take out 120 μL from it and spread it on YPD, culture it for 2-3 days, select a single clone, spot it on 15 mg / L Phleo plate and 0.5 g / L G418 resistance plate, select the clone that does not grow on the two resistance plates, and streak it on YPD for purification (choose whether to purify according to the actual situation).

[0132] The correctly sterilized strain was named SHF16, classified as Saccharomyces cerevisiae, deposit number: CGMCC No.28947, deposit unit: General Microbiology Center of China Culture Collection Administration, deposit time: November 13, 2023, deposit address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing.

[0133] The fermentation was verified according to the shake flask fermentation method mentioned above. The results are shown in Figure 5 The SAMe production of SHF16G fermentation was 1.68g / L, and the SAMe production of SHF16 fermentation was 1.7g / L. After SHF16G was sterilized, the SAMe production did not decrease.

Claims

1. A genetically engineered strain, characterized in that: The genetically engineered strain is used to produce SAMe; the construction method of the genetically engineered strain is: overexpressing the apt1-prs128 gene in a basic strain that overexpresses the SAM2 gene; the nucleotide sequence of the apt1-prs128 gene includes SEQ ID No.17 or a functional fragment thereof; the genetically engineered strain is yeast SHF16, and the preservation number is CGMCC No.28947.

2. Use of the genetically engineered strain according to claim 1 in SAMe production.

3. A method for producing SAMe, characterized in that: The following steps are involved: (1) Activation of the genetically engineered strain according to claim 1; (2) Fermentation; (3) Extraction of SAMe.

4. The production method according to claim 3, characterized in that: The step (1) comprises: taking a single bacterial colony and inoculating it into YPD and activating it overnight; The step (2) comprises: transferring the activated seeds to a fermentation medium for fermentation; The step (3) comprises: taking fermentation broth, adding perchloric acid, water bathing, centrifuging, filtering the supernatant with an aqueous membrane, and then detecting with HPLC.